Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Cyclacel Pharmaceuticals Inc - SIC # 2834 - PHARMACEUTICAL PREPARATIONS
Ticker
Exchange
SIC #
Website
Latest Ticker
CYCC
Nasdaq
2834
https://cyclacel.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Cyclacel Pharmaceuticals Inc
Q2 2023 Cyclacel Pharmaceuticals Inc Earnings Call
- Aug 10th, 2023 10:42 am
Cyclacel Pharmaceuticals Reports Second Quarter Financial Results and Provides Business Update
- Aug 9th, 2023 8:05 pm
Cyclacel Pharmaceuticals to Release Second Quarter 2023 Financial Results
- Aug 3rd, 2023 1:15 pm
Cyclacel Pharmaceuticals, Inc. (CYCC) Upgraded to Strong Buy: Here's Why
- Jul 13th, 2023 4:00 pm
Q1 2023 Cyclacel Pharmaceuticals Inc Earnings Call
- May 12th, 2023 9:52 am
Cyclacel Pharmaceuticals Reports First Quarter Financial Results and Provides Business Update
- May 11th, 2023 8:05 pm
Cyclacel Pharmaceuticals to Release First Quarter 2023 Financial Results
- May 4th, 2023 1:15 pm
Cyclacel Pharmaceuticals Announces Receipt of $4.7 Million R&D Tax Credit
- May 3rd, 2023 1:15 pm
Cyclacel Pharmaceuticals to Participate in March Investor Conferences
- Mar 7th, 2023 2:15 pm
Q4 2022 Cyclacel Pharmaceuticals Inc Earnings Call
- Mar 7th, 2023 11:10 am
Cyclacel Pharmaceuticals Reports Fourth Quarter And Full Year 2022 Financial Results And Provides Business Update
- Mar 6th, 2023 9:05 pm
Cyclacel Pharmaceuticals to Release Fourth Quarter and Full Year 2022 Financial Results
- Feb 27th, 2023 2:15 pm
Cyclacel Pharmaceuticals to Participate in the 2023 BIO CEO & Investor Conference
- Jan 30th, 2023 2:15 pm
Cyclacel Pharmaceuticals Reviews 2022 Achievements and Announces Key Business Objectives for 2023
- Jan 5th, 2023 2:15 pm
Cyclacel Pharmaceuticals to Present at Biotech Showcase and Participate in a Corporate Access Event During the J.P. Morgan Healthcare Conference in January 2023
- Dec 15th, 2022 2:15 pm
Cyclacel Pharmaceuticals Reports Third Quarter 2022 Financial Results and Provides Business Update
- Nov 9th, 2022 9:05 pm
Here's What to Expect Ahead of Wix's (WIX) Q3 Earnings Release
- Nov 7th, 2022 3:33 pm
Cyclacel Pharmaceuticals to Release Third Quarter 2022 Financial Results
- Nov 3rd, 2022 1:15 pm
Cyclacel Reports Preliminary Data From Its Phase 1/2 Clinical Trial of Oral Fadraciclib in Patients With Solid Tumors and Lymphoma at ENA 2022
- Oct 26th, 2022 1:15 pm
Cyclacel Hosting Research & Development Day
- Oct 24th, 2022 1:15 pm
Scroll